Cite
HARVARD Citation
Harter, P. et al. (n.d.). Phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab. International journal of gynecological cancer. pp. A10-A11. [Online].